EUVIMEDEUVIMED entdecken
Crossref

A Novel Method for Liraglutide Synthesis and Purification

Gabriela R. Barredo‐Vacchelli, Jésica A. Rodríguez, Joaquin A. Eloy, Silvia A. Camperi

Peptide Science · 2024-09 · 116 (5)

DOI: 10.1002/pep2.24351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peptide Science, online erschienen am 03.05.2024. Verfasst von Gabriela R. Barredo‐Vacchelli und 3 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Universidad de Buenos Aires.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liraglutide, developed by Novo Nordisk, is applied in Type 2 diabetes and obesity treatment. Several solid‐phase peptide synthesis protocols were designed for its production. However, current protocols are expensive and many of them are difficult to scale‐up. In this study, a novel alternative for liraglutide production was developed. The peptide was elongated by Fmoc/tBu solid‐phase peptide synthesis on 4‐hydroxymethylbenzoyl–ChemMatrix (HMBA‐CM) resin using the chaotropic agent LiCl as an additive to prevent peptide aggregation. After elongation, removal of side‐chain protecting groups and peptide cleavage from the resin was performed by a two‐stage procedure. Side‐chain protecting groups were removed with 92.5% TFA, leaving the unprotected peptide attached to the solid support. The resin was thoroughly washed to eliminate the contaminants. Next, peptide release was achieved by treating the peptidyl resin with NaOH 0.1 N. This two‐stage procedure assures a high‐purity product without the need of using a large amount of ether as in previous protocols. Finally, liraglutide was purified by hydrophobic interaction with low‐pressure liquid chromatography (HI‐LPLC) instead of using the expensive RP‐HPLC applied in reported methods. This simple and economic method resulted in a high yield and a purity product while overcoming the high cost and difficulties of current processes.

Förderung

  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • Universidad de Buenos Aires

Zitieren

APA

Barredo‐Vacchelli, G. R., Rodríguez, J. A., Eloy, J. A., & Camperi, S. A. (2024). A Novel Method for Liraglutide Synthesis and Purification. Peptide Science, 116(5). https://doi.org/10.1002/pep2.24351

Vancouver

Barredo‐Vacchelli GR, Rodríguez JA, Eloy JA, Camperi SA. A Novel Method for Liraglutide Synthesis and Purification. Peptide Science. 2024;116(5). doi:10.1002/pep2.24351

BibTeX
@article{BarredoVacchelli2024,
  author = {Barredo‐Vacchelli, Gabriela R. and Rodríguez, Jésica A. and Eloy, Joaquin A. and Camperi, Silvia A.},
  title = {A Novel Method for Liraglutide Synthesis and Purification},
  journal = {Peptide Science},
  year = {2024},
  volume = {116},
  number = {5},
  doi = {10.1002/pep2.24351}
}
Kostenlos starten →